In the development of Biopharmaceuticals (proteins, peptides and cellular therapeutics) and biotechnology derived in vivo diagnostics early on definition of the regulatory strategy is one of the most important cornerstones of success. The specific challenge of biopharmaceutical drug development is the need to scientifically interpret regulatory guidelines in very close context to the molecular structure and mode of action characteristics of the molecule of interest. This alignment leads into a tailored regulatory concept that addresses the drug specificities.
Swiss Biotech™ detected this early on and established a regulatory platform with experts. regulanet™ is our partner for this platform.
Experts from regulanet™ are at disposal for an initial 1hour free-of charge consultation if your scientific concept or development program is facing specific regulatory issues.
Your request will be handled by Dr. Tobias Ostler, Senior Manager Scientific Affairs Biopharmaceuticals at Dr. Regenold GmbH (http://www.regenold.com/).
Contact: Your Request will be handled strictly confidential. Please fill in belwo box and press the send button:
Zum Seitenanfang
